SRSF2 and urinary bladder cancer: Furthermore, low expression levels of LOXL4 and SRSF2 – genes regulated by miR-29b-3p and miR-193a-3p (see Supplementary Table S2) – have been associated with inhibited apoptosis and enhanced multi-drug resistance in bladder cancer (122).